We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+5.19%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.3B
AUM Growth
-$24.3M
(-1.8%)
Cap. Flow
-$1.65M
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
72
New
14
Increased
18
Reduced
22
Closed
16
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$54.1M |
| 2 |
Boston Scientific
BSX
|
+$40.3M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$40.2M |
| 4 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.8M |
| 5 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$22.4M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
+$49M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
+$40.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$38.8M |
| 4 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
+$33.8M |
| 5 |
Incyte
INCY
|
+$28.5M |
Sector Composition
| 1 | Healthcare | 79.19% |
| 2 | Communication Services | 1.61% |
| 3 | Industrials | 0.58% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $99.7M | 7.7% |
10,280,620
+1,947,690
| +23% | +$17.6M |
|
|
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
| $77.3M | 5.97% |
1,599,393
-153,249
| -9% | -$6.61M |
|
3
Penumbra
PEN
$12.5B
| $76.2M | 5.88% |
1,537,570
-25,017
| -2% | -$1.13M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $75.3M | 5.81% |
17,850,650
+100,140
| +0.6% | +$457K |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $65.8M | 5.08% |
1,223,717
-98,875
| -7% | -$4.99M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $62.9M | 4.85% |
1,795,936
+838,302
| +88% | +$54.1M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $61.6M | 4.75% |
1,372,492
-17,681
| -1% | -$736K |
|
8
Teva Pharmaceuticals
TEVA
$37B
| $61.6M | 4.75% |
938,139
-199,420
| -18% | -$12.3M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $55.9M | 4.31% |
958,374
-184,490
| -16% | -$9.14M |
|
|
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $49.3M | 3.8% |
958,155
+188,514
| +24% | +$9.14M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $44M | 3.4% |
562,873
+48,600
| +9% | +$4.03M |
|
|
12
Ironwood Pharmaceuticals
IRWD
$665M
| $42.6M | 3.28% |
4,383,585
+4,155,783
| +1,824% | +$40.2M |
|
|
13
Boston Scientific
BSX
$64.6B
| $41.5M | 3.2% |
+2,251,020
| New | +$40.3M |
|
14
Atara Biotherapeutics
ATRA
$76.3M
| $40.5M | 3.13% |
61,398
+19,407
| +46% | +$14.7M |
|
|
15
Incyte
INCY
$23B
| $38.8M | 3% |
357,912
-255,686
| -42% | -$28.5M |
|
|
DPLO
16
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $38.2M | 2.95% |
+1,115,902
| New | +$34.8M |
|
|
NVRO
17
DELISTED
NEVRO CORP.
NVRO
| $28M | 2.16% |
415,198
+390,198
| +1,561% | +$20.9M |
|
|
NDRM
18
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $27.1M | 2.09% |
1,589,261
+126,562
| +9% | +$2.47M |
|
19
Centene
CNC
$33B
| $26.9M | 2.07% |
816,000
-678,920
| -45% | -$20.1M |
|
20
Insmed
INSM
$23.7B
| $25.3M | 1.95% |
1,391,813
+443,847
| +47% | +$7.82M |
|
21
UnitedHealth
UNH
$382B
| $22M | 1.7% |
+187,034
| New | +$21.9M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $21.5M | 1.66% |
+68,758
| New | +$20.5M |
|
|
MODN
23
DELISTED
MODEL N, INC.
MODN
| $20.8M | 1.61% |
1,868,159
+424,881
| +29% | +$4.53M |
|
|
ZLTQ
24
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $20.2M | 1.56% |
+709,426
| New | +$22.4M |
|
|
NSTG
25
DELISTED
NanoString Technologies, Inc.
NSTG
| $20M | 1.54% |
1,357,692
-27,949
| -2% | -$411K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO